Caroline Gaynor, Principal
Caroline joined Lightstone Ventures in 2017 and evaluates new investment opportunities in the biopharmaceutical and medical device sectors out of the firm’s Dublin office.
Caroline has over 10 years’ operational experience in the pharmaceutical industry. Caroline was a consultant to a number of biopharma and medtech focused start-ups prior to joining Lightstone. She was on the board of senior management for Bayer Ltd. Ireland as head of market access & reimbursement and was responsible for health economics, health technology assessment applications and reimbursement/pricing negotiations for new drugs. Prior to Bayer, she held roles in regulatory affairs, product management, marketing and strategic business development.
Caroline completed the Bioinnovate Fellowship program in 2013. She has helped secure funding for and worked with a number of early stage medical device companies in the role of clinical/commercial lead since.
Caroline is currently on the board of ALX Oncology and observer to the board of Carrick Therapeutics, Cerevance and FIRE-1. She is a member of the BioInnovate Ireland Board of advisors.
B.S. in Pharmacy from Trinity College Dublin
M.S. in Pharmaceutical Medicine from Trinity College Dublin
M.S. in BioInnovation from National University of Ireland, Galway
Sector: Biopharmaceuticals, Medical Devices
See other team members.